Published in J Cell Physiol on April 01, 2005
Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther (2007) 1.85
Effects of age and gender on WNT gene expression in human bone marrow stromal cells. J Cell Biochem (2009) 0.88
Mesenchymal stem cells as trophic mediators. J Cell Biochem (2006) 9.38
A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med (2004) 4.37
In search of the in vivo identity of mesenchymal stem cells. Stem Cells (2008) 4.17
Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev (2009) 3.73
Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol (2011) 3.65
Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med (2013) 2.60
FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol (2005) 2.31
A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med (2009) 2.31
The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs (2002) 1.95
Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models. Nat Neurosci (2012) 1.86
Isolation and characterization of a population of immature dental pulp stem cells expressing OCT-4 and other embryonic stem cell markers. Cells Tissues Organs (2006) 1.82
Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials (2007) 1.78
Effects of initial seeding density and fluid perfusion rate on formation of tissue-engineered bone. Tissue Eng Part A (2008) 1.70
Diagnosis and management of infection after total knee arthroplasty. J Bone Joint Surg Am (2003) 1.63
Isolation of human marrow-derived mesenchymal stem cells. Exp Hematol (2006) 1.60
Effect of changing indications and techniques on total hip resurfacing. Clin Orthop Relat Res (2007) 1.57
Immunochemical and mechanical characterization of cartilage subtypes in rabbit. J Histochem Cytochem (2002) 1.56
Adult stem cell driven genesis of human-shaped articular condyle. Ann Biomed Eng (2004) 1.56
Fibroblast heterogeneity: more than skin deep. J Cell Sci (2004) 1.55
Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol (2010) 1.46
Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol (2009) 1.46
Chondrogenesis of adult stem cells from adipose tissue and bone marrow: induction by growth factors and cartilage-derived matrix. Tissue Eng Part A (2010) 1.45
In vivo degradation of polyethylene liners after gamma sterilization in air. J Bone Joint Surg Am (2005) 1.43
Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. Tissue Eng Part A (2010) 1.38
Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic Biol Med (2002) 1.35
Mesenchymal stem cells in tissue repair. Front Immunol (2013) 1.35
MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation. Stem Cells Int (2013) 1.30
Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J Pharmacol Exp Ther (2003) 1.29
Isolation of rat marrow-derived mesenchymal stem cells. Exp Hematol (2006) 1.29
Topical delivery of mesenchymal stem cells and their function in wounds. Stem Cell Res Ther (2010) 1.28
Targeting improves MSC treatment of inflammatory bowel disease. Mol Ther (2010) 1.28
Fibroblasts-a diverse population at the center of it all. Int Rev Cell Mol Biol (2009) 1.27
Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues. PLoS One (2008) 1.26
Cartilage repair: past and future--lessons for regenerative medicine. J Cell Mol Med (2009) 1.24
2006 Otto Aufranc Award Paper: significance of in vivo degradation for polyethylene in total hip arthroplasty. Clin Orthop Relat Res (2006) 1.23
Influence of adult mesenchymal stem cells on in vitro vascular formation. Tissue Eng Part A (2009) 1.22
MSC frequency correlates with blood vessel density in equine adipose tissue. Tissue Eng Part A (2009) 1.21
Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle. Tissue Eng (2002) 1.20
Cartilage tissue engineering for laryngotracheal reconstruction: comparison of chondrocytes from three anatomic locations in the rabbit. Tissue Eng (2007) 1.19
Effect of dual growth factor delivery on chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in injectable hydrogel composites. J Biomed Mater Res A (2009) 1.18
Effect of swelling ratio of injectable hydrogel composites on chondrogenic differentiation of encapsulated rabbit marrow mesenchymal stem cells in vitro. Biomacromolecules (2009) 1.18
Bioreactors mediate the effectiveness of tissue engineering scaffolds. FASEB J (2002) 1.15
Targeted delivery of progenitor cells for cartilage repair. J Orthop Res (2004) 1.15
Cementless two-staged total hip arthroplasty for deep periprosthetic infection. Clin Orthop Relat Res (2005) 1.14
The role of osteoclast differentiation in aseptic loosening. J Orthop Res (2002) 1.13
One-step derivation of mesenchymal stem cell (MSC)-like cells from human pluripotent stem cells on a fibrillar collagen coating. PLoS One (2012) 1.12
Does endotoxin contribute to aseptic loosening of orthopedic implants? J Biomed Mater Res B Appl Biomater (2005) 1.11
Repair of osteochondral defects with hyaluronan- and polyester-based scaffolds. Osteoarthritis Cartilage (2005) 1.11
Repair of osteochondral defect with tissue-engineered two-phase composite material of injectable calcium phosphate and hyaluronan sponge. Tissue Eng (2002) 1.09
Hyaluronan-based polymer scaffold modulates the expression of inflammatory and degradative factors in mesenchymal stem cells: Involvement of Cd44 and Cd54. J Cell Physiol (2006) 1.09
Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes. J Orthop Res (2003) 1.08
Polyethylene and titanium particles induce osteolysis by similar, lymphocyte-independent, mechanisms. J Orthop Res (2005) 1.08
Generation of pluripotent stem cells and their differentiation to the chondrocytic phenotype. Methods Mol Med (2004) 1.07
Defining human mesenchymal stem cell efficacy in vivo. J Inflamm (Lond) (2010) 1.06
Targeting mesenchymal stem cells to activated endothelial cells. Biomaterials (2009) 1.06
Hydrostatic pressure induces apoptosis in human chondrocytes from osteoarthritic cartilage through up-regulation of tumor necrosis factor-alpha, inducible nitric oxide synthase, p53, c-myc, and bax-alpha, and suppression of bcl-2. J Cell Biochem (2002) 1.06
In vitro dexamethasone pretreatment enhances bone formation of human mesenchymal stem cells in vivo. J Orthop Res (2009) 1.05
Chondrogenesis and mineralization during in vitro culture of human mesenchymal stem cells on three-dimensional woven scaffolds. Tissue Eng Part A (2010) 1.04
A rapid seeding technique for the assembly of large cell/scaffold composite constructs. Tissue Eng (2006) 1.03
In vitro generation of mechanically functional cartilage grafts based on adult human stem cells and 3D-woven poly(epsilon-caprolactone) scaffolds. Biomaterials (2010) 1.02
Efficient osteoclast differentiation requires local complement activation. Blood (2010) 1.02
The potential of mesenchymal stem cells for neural repair. Discov Med (2010) 1.01
Hyaluronan-based scaffolds to tissue-engineer cartilage implants for laryngotracheal reconstruction. Laryngoscope (2007) 1.01
Bacterial pathogen-associated molecular patterns stimulate biological activity of orthopaedic wear particles by activating cognate Toll-like receptors. J Biol Chem (2010) 1.00
Tissue engineering of autologous cartilage grafts in three-dimensional in vitro macroaggregate culture system. Tissue Eng (2005) 1.00
Analysis of retrieved ultra-high-molecular-weight polyethylene tibial components from rotating-platform total knee arthroplasty. J Arthroplasty (2008) 0.99
Fabrication of a neotrachea using engineered cartilage. Laryngoscope (2008) 0.98
The effects of crosslinking of scaffolds engineered from cartilage ECM on the chondrogenic differentiation of MSCs. Biomaterials (2013) 0.98
Scaling-up of dental pulp stem cells isolated from multiple niches. PLoS One (2012) 0.98
Age-related changes in the proteoglycans of human skin. Specific cleavage of decorin to yield a major catabolic fragment in adult skin. J Biol Chem (2003) 0.98
Methods for producing scaffold-free engineered cartilage sheets from auricular and articular chondrocyte cell sources and attachment to porous tantalum. Biores Open Access (2012) 0.96
A self-assembled fibroblast-endothelial cell co-culture system that supports in vitro vasculogenesis by both human umbilical vein endothelial cells and human dermal microvascular endothelial cells. Cells Tissues Organs (2007) 0.96
Nondestructive evaluation of hydrogel mechanical properties using ultrasound. Ann Biomed Eng (2011) 0.96
Age-related differences in human skin proteoglycans. Glycobiology (2010) 0.96
Adult mesenchymal stem cells: an innovative therapeutic for lung diseases. Discov Med (2010) 0.96
Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations. Tissue Eng Part B Rev (2014) 0.96
The balance between endotoxin accumulation and clearance during particle-induced osteolysis in murine calvaria. J Orthop Res (2007) 0.95
Stem cells in dental pulp of deciduous teeth. Tissue Eng Part B Rev (2011) 0.95
Hemostasis using a bipolar sealer in primary unilateral total knee arthroplasty. Am J Orthop (Belle Mead NJ) (2009) 0.95